Conventional pharmacological treatments for type 2 diabetes primarily aim to increase insulin levels rather than reduce glucose directly.

“most of the approaches to type 2 diabetes pharmacologically are not actually aimed at reducing glucose metformin is one of the very few drugs you mentioned the SGO till to inhibit sglt2 inhibitors which want to come back to so will carve out the ones that actually lower glucose but most of them are trying to amplify the noise so walk us through the classes of those drugs so we have the sulfonylureas which stimulate insulin and there's insulin which stimulates insulin and the dpp-4 is for example which are also similar in terms of they increase insulin this”